According to Cognitive Market Research, The Global Neurological Biomarkers market size is USD 7.5 billion in 2023 and will expand at a compound annual growth rate (CAGR) of 13.20% from 2023 to 2030.
The demand for Neurological Biomarkers is rising due to the the increasing prevalence of neurological diseases.
Demand for Proteomics based biomarkers remains higher in the Neurological Biomarkers market.
The Hospitals category held the highest Neurological Biomarkers market revenue share in 2023.
North American Neurological Biomarkers will continue to lead, whereas the European Neurological Biomarkers market will experience the most substantial growth until 2030.
